Keep MASLD Diagnostic Revenue In-House
How small hepatology practices and primary care super-clinics can achieve ROI in under 500 scans with the iLivTouch system.
Stop Referring Out Your Diagnostic Revenue
As of 2026, 38% of Australians have some form of fatty liver disease. GPs and specialists are overwhelmed by the sheer volume of patients requiring assessment.
Currently, many primary care "Super-Clinics" refer these patients out for FibroScan or ultrasound assessments, losing valuable diagnostic revenue and delaying patient care.
By bringing elastography in-house, you not only streamline the patient pathway but also capture a significant new revenue stream for your practice.
- Keep diagnostic revenue within your clinic
- Provide immediate answers to anxious patients
- Reduce specialist referral bottlenecks
The Primary Care Opportunity
With the rising prevalence of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), front-line screening is shifting to primary care. Clinics equipped with point-of-care elastography are positioned to become regional diagnostic hubs.
The ROI Advantage
Guided elastography combines real-time imaging with a single-probe workflow. Use the ROI calculator below with your own capital, volume, and fee assumptions to model payback for your clinic.
Blind elastography workflows
- ✕High barrier to entry for small practices
- ✕Longer time to achieve ROI
- ✕Often requires high volume to justify
iLivTouch System
- Accessible entry point for private practice
- Achieve ROI in under 500 scans
- Advanced 2D ultrasound guidance included
The Path to Profitability
Model payback in a busy clinic environment using your own capital, scan volume, and fee assumptions.
Ready to Capture Your Diagnostic Revenue?
Contact our team to discuss how the iLivTouch system can integrate into your clinic's workflow and provide a rapid return on investment.